Loading clinical trials...
Loading clinical trials...
A Randomized, Placebo-Controlled, Double-Blind, Crossover Study of Oral BTD-001 in Adults With Idiopathic Hypersomnia
Conditions
Interventions
Pentetrazol (PTZ)
Placebo oral capsule
Locations
32
United States
Sleep Disorders Center of Alabama
Birmingham, Alabama, United States
Mayo Clinic Hospital
Scottsdale, Arizona, United States
SDS Clinical Trials
Orange, California, United States
Pacific Research Network
San Diego, California, United States
Sleep Medicine Specialists of California
San Ramon, California, United States
Santa Monica Clinical Trials
Santa Monica, California, United States
Start Date
May 29, 2018
Primary Completion Date
May 1, 2020
Completion Date
May 28, 2020
Last Updated
April 29, 2020
NCT06457945
NCT05615584
NCT04330963
NCT05321355
NCT05371483
NCT06525077
Lead Sponsor
Balance Therapeutics
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions